Show simple item record

dc.contributor.authorSohrabi, N
dc.contributor.authorFarajnia, S
dc.contributor.authorAkhi, MT
dc.contributor.authorNahaei, MR
dc.contributor.authorNaghili, B
dc.contributor.authorPeymani, A
dc.contributor.authorAmiri, Z
dc.contributor.authorRezaee, MA
dc.contributor.authorSaeedi, N
dc.date.accessioned2018-08-26T09:32:37Z
dc.date.available2018-08-26T09:32:37Z
dc.date.issued2012
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/57385
dc.description.abstractCarbapenems have been considered as last line antibiotics for treatment of multidrug-resistant (MDR) Acinetobacter baumannii but carbapenem resistant A. baumannii has been increased during the last decade in many parts of the world. OXA-type ?-lactamase enzymes are the most common cause of carbapenem resistance in A. baumannii and presence of ISAba1 in upstream of these genes may increase the expression of these OXA genes. The aim of this study was to determine, for the first time, the antibiotic resistance pattern and prevalence of OXA type ?-lactamases among nosocomial A. baumannii isolates from northwest of Iran. A total of 100 A. baumannii isolates were recovered from hospitalized patients in a university hospital in northwest of Iran. Sixty-two percent of isolates were resistant to imipenem. All isolates carried bla OXA-51-like gene. Among imipenem resistant isolates, 88.7% carried blaOXA-23-like, 1.6% carried blaOXA-40-like, and 3.2% had blaOXA-58-like resistance genes. Ninety percent of isolates contained ISAba1 element and in 74.2% of imipenem resistant isolates, ISAba1 was located in upstream of blaOXA-23-like. The results of this study demonstrated high prevalence of OXA-type carbapenemase among MDR A. bumanii in the Northwest of Iran. é 2012 Mary Ann Liebert, Inc.
dc.language.isoEnglish
dc.relation.ispartofMicrobial Drug Resistance
dc.subjectamikacin
dc.subjectampicillin
dc.subjectantibiotic agent
dc.subjectbacterial DNA
dc.subjectbeta lactam antibiotic
dc.subjectbeta lactamase
dc.subjectcarbapenem
dc.subjectcefepime
dc.subjectceftazidime
dc.subjectceftriaxone
dc.subjectciprofloxacin
dc.subjectclavulanic acid
dc.subjectcolistin
dc.subjectcotrimoxazole
dc.subjectgentamicin
dc.subjectimipenem
dc.subjectlevofloxacin
dc.subjectmeropenem
dc.subjectpiperacillin
dc.subjectpiperacillin plus tazobactam
dc.subjectpolymyxin B
dc.subjectsulbactam
dc.subjectticarcillin
dc.subjectAcinetobacter baumannii
dc.subjectantibiotic resistance
dc.subjectarticle
dc.subjectbacterial growth
dc.subjectbacterium culture
dc.subjectbacterium isolate
dc.subjectcontrolled study
dc.subjectGram negative bacterium
dc.subjectgrowth inhibition
dc.subjecthospital infection
dc.subjecthospital patient
dc.subjecthuman
dc.subjectIran
dc.subjectnonhuman
dc.subjectpolymerase chain reaction
dc.subjectprevalence
dc.subjectpriority journal
dc.subjectPseudomonas aeruginosa
dc.subjectAcinetobacter baumannii
dc.subjectAcinetobacter Infections
dc.subjectAdult
dc.subjectAged
dc.subjectAnti-Bacterial Agents
dc.subjectBacterial Typing Techniques
dc.subjectbeta-Lactam Resistance
dc.subjectbeta-Lactamases
dc.subjectCarbapenems
dc.subjectDNA Transposable Elements
dc.subjectFemale
dc.subjectGenes, Bacterial
dc.subjectHumans
dc.subjectIran
dc.subjectMale
dc.subjectMicrobial Sensitivity Tests
dc.subjectMiddle Aged
dc.subjectPlasmids
dc.subjectPolymerase Chain Reaction
dc.subjectAcinetobacter baumannii
dc.titlePrevalence of oxa-type ?-lactamases among Acinetobacter baumannii isolates from northwest of Iran
dc.typeArticle
dc.citation.volume18
dc.citation.issue4
dc.citation.spage385
dc.citation.epage389
dc.citation.indexScopus
dc.identifier.DOIhttps://doi.org/10.1089/mdr.2011.0077


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record